Olema Pharmaceuticals announces $190M follow-on offering of 10M shares at $19.00

Olema Pharmaceuticals, Inc.

Offering of 10,000,000 shares of common stock at $19.00 per share for gross proceeds of ~$190M.
Underwriters have a 30-day option to purchase up to 1,500,000 additional shares.
Closing expected on November 20, 2025, subject to customary conditions.
Underwriting agreement with TD Securities (USA) LLC as representative of the underwriters.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.